Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ascendis Pharma A/S - American Depositary Shares
(NQ:
ASND
)
205.44
-3.14 (-1.51%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ascendis Pharma A/S - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
This Twilio Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
↗
May 05, 2025
Via
Benzinga
Earnings Scheduled For May 1, 2025
↗
May 01, 2025
Via
Benzinga
A Glimpse of Ascendis Pharma's Earnings Potential
↗
April 30, 2025
Via
Benzinga
Why ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) could fit Mark Minervini’s high-growth criteria
↗
April 28, 2025
A fundamental and technical analysis of (NASDAQ:ASND): Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) suited for high growth investing?
Via
Chartmill
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
↗
April 15, 2025
Via
Benzinga
Does ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) show the characteristics of a Minervini super stock?
↗
April 04, 2025
A fundamental and technical analysis of (NASDAQ:ASND): Why the high growth investor may take a look at ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND).
Via
Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today
↗
March 04, 2025
Via
Benzinga
Here's How Much $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
↗
February 19, 2025
Via
Benzinga
Earnings Scheduled For February 12, 2025
↗
February 12, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
↗
January 23, 2025
Via
Benzinga
Looking Into Ascendis Pharma's Recent Short Interest
↗
March 26, 2025
Via
Benzinga
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
↗
March 25, 2025
Via
Benzinga
Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) a Minervini-style stock?
↗
March 14, 2025
A fundamental and technical analysis of (NASDAQ:ASND): Why the high growth investor may take a look at ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND).
Via
Chartmill
Why Is BioMarin Stock Trading Higher On Thursday?
↗
February 20, 2025
BioMarin exceeded Q4 earnings expectations, raised 2025 guidance, and projected strong Voxzogo growth. Analysts increased price targets following the results.
Via
Benzinga
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
↗
February 13, 2025
Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch. Goldman Sachs raised its price target.
Via
Benzinga
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing
↗
February 13, 2025
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.
Via
Stocktwits
Looking Into Ascendis Pharma's Recent Short Interest
↗
January 15, 2025
Via
Benzinga
Peering Into Ascendis Pharma's Recent Short Interest
↗
December 03, 2024
Via
Benzinga
(ASND) - Analyzing Ascendis Pharma's Short Interest
↗
November 14, 2024
Via
Benzinga
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
January 07, 2025
Via
Benzinga
Can BioMarin Stock Live Up to Wall Street’s High Expectations?
November 22, 2024
BioMarin has greatly improved the fundamentals of its business, but continues losing value. Is the tide ready to turn, or is more of the same on the horizon?
Via
MarketBeat
A Glimpse of Ascendis Pharma's Earnings Potential
↗
November 13, 2024
Via
Benzinga
Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?
↗
November 05, 2024
Novo Nordisk is expected to report third-quarter earnings on Wednesday. Stock up 8.55% in a year, 7.45% year-to-date.
Via
Benzinga
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
↗
November 04, 2024
Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments.
Via
Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $5,600 Today
↗
November 04, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
↗
October 08, 2024
Via
Benzinga
Looking Into Ascendis Pharma's Recent Short Interest
↗
September 26, 2024
Via
Benzinga
Earnings Scheduled For November 14, 2024
↗
November 14, 2024
Via
Benzinga
BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth
↗
October 30, 2024
BioMarin posts Q3 EPS of $0.91, nearly doubling last year's $0.46 and topping estimates. Sales rose 28%, driven by strong Voxzogo growth. Analyst downgrades on lack of upcoming catalysts.
Via
Benzinga
3 Oversold Stocks with Big RSI Rebound Potential
October 03, 2024
Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. The RSI indicator is a great way to find them.
Via
MarketBeat
Topics
Economy
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
